TABLE 3.
Treatment/Clinical Outcome
| Case | Therapy | Effect | Overall Survival | Outcome |
|---|---|---|---|---|
| 1 | NA | NA | NA | NA |
| 2 | Aspiration | NA | 5 (mo) | Died (AIDS dementia) |
| 3 | Unspecified chemo | Aborted due to toxicity | 1 | Died |
| 4 | Aspiration | Spontaneous CR | 2 | Died (complications of HCC) |
| 5 | CHOP | CR; ascites remained | 12 | Died (traumatic subdural) |
| 6 | Aspiration | Spontaneous CR | 24 | Alive |
| 7 | Prednisolone, etoposide | CR | 8 | Alive |
| 8 | NA | NA | NA | Died |
| 9 | NA | NA | 8 | Alive |
| 10 | Aspiration | Spontaneous CR | 7 | Died (unrelated cerebral bleeding) |
| 11 | CHOP | CR | 15 | Died |
| 12 | CHOP, SCT | CR | 13 | Alive |
| 13 | Aspiration | NR | 2 | Alive |
| 14 | COP | PR, multiple recurrences | 5 | Died |
| 15 | Prednisolone | NR | 0.6 | Died |
| 16 | Aspiration | NR | 5 | Died |
| 17 | Orchiectomy, MEP-carboplatin, local radiation | CR | 8 | Alive |
| 18 | CHOP | CR | 5 | Died (pneumonia/pancreatitis) |
| 19 | CHOP, THP-COP, sobuzoxane | CR | 18 | Alive |
| 20 | R+THP-COP | CR | 26 | Alive |
| 21 | THP-COP, SCT | CR | 18 | Died (extensive bleeding from hemangioma) |
| 22 | CHOP | CR | 36 | Alive |
| 23 | Vincristine & cyclophosphamide | CR | NA | Alive |
| 24 | R+THP-COP, etoposide | PR | 25 | Alive |
| 25 | Rituximab | CR | 28 | Alive |
| 26 | Endoxan, farmorubicin, oncovin, prezolon | NA | 0.7 | Died (operative complications) |
| 27 | R+CHOP | CR | 9 | Alive |
| 28 | R+CHOP | Spontaneous CR after aspiration maintained after chemo | 22 | Alive |
| 29 | R+THP-COP | CR | 30 | Alive |
| 30 | Aspiration | Spontaneous CR; ascites returned without lymphoma | 40 | Alive |
| 31 | R+COP | NR | 3 | Alive |
| 32 | VelCD | Initial response, then recurrence | 2.1 | Died |
| 33 | CHOP | NR | 7 | Died |
| 34 | R+CHOP | CR; ascites remained | 12 | Alive |
| 35 | R+CHOP | CR; ascites remained | NA | Alive |
| 36 | CHOP | PR | 2 | Died (complications of Mallory Weiss tear) |
| 37 | R+CHOP | CR; ascites remained | NA | Died |
| 38 | Pleurodesis | Spontaneous CR | 55 | Alive |
| 39 | Aspiration | Spontaneous CR | 16 | Died |
| 40 | Aspiration | Spontaneous CR | 11 | Alive |
| 41 | Aspiration | NA | NA | NA |
| 42 | ICE, BCNU-ECM, SCT | Initial response, then recurrence | 4.5 | Died |
| 43 | CHOP | Aborted due to toxicity | 1.5 | Died |
| 44 | Aspiration | NA | NA | NA |
| 45 | Aspiration | NR | 0.03 | Died |
AIDS indicates acquired immunodeficiency syndrome; BCNU-ECM, BCNU, etoposide, cytarabine, melphalan; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisolone; COP, cyclophosphamide, vincristine, prednisolone; ICE, ifosphamide, carboplatin, etoposide; MEP, mitoxantrone, etoposide, and prednisone; NA, not applicable; NR, no response; R, rituximab; SCT, stem cell transplant; THP-COP, pirarubicin, vincristine, cyclophosphamide, prednisolone; VelCD, bortezomib cyclo-phosphamide dexamethasone.